Marshall Wace’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-146,232
| Closed | -$1.4M | – | 3021 |
|
|
2024
Q4 | $1.4M | Buy |
146,232
+106,039
| +264% | +$1.02M | ﹤0.01% | 1462 |
|
|
2024
Q3 | $115K | Buy |
40,193
+29,655
| +281% | +$84.8K | ﹤0.01% | 2184 |
|
|
2024
Q2 | $30.8K | Buy |
+10,538
| New | +$30.8K | ﹤0.01% | 2239 |
|
|
2023
Q3 | – | Sell |
-40,760
| Closed | -$71.7K | – | 2447 |
|
|
2023
Q2 | $71.7K | Sell |
40,760
-407,985
| -91% | -$718K | ﹤0.01% | 1912 |
|
|
2023
Q1 | $1.38M | Sell |
448,745
-62,659
| -12% | -$193K | ﹤0.01% | 1300 |
|
|
2022
Q4 | $2.71M | Buy |
+511,404
| New | +$2.71M | 0.01% | 1247 |
|